Effect of Ultra-low Dose Naloxone on Remifentanil-Induced Hyperalgesia
Clinical trial NCT03066739 · TERMINATED
Trial details
- NCT number
- NCT03066739
- Sponsor
- University of California, Irvine
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-02-25
- Primary completion
- 2024-12-10
- Enrollment
- 8
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.